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A study on the eﬀective substance of the Wu-tou
formula based on the metabonomic method using
UPLC-Q-TOF-HDMS
Tengfei Xu,ab Shu Liu,a Jiadi Zhao,ab Guifang Feng,ab Zifeng Pi,*a Fengrui Songa and
Zhiqiang Liu*a
The Wu-tou formula (WTF) is a Chinese medicine formula which has been applied to treat rheumatic
arthritis (RA) and pain of joints for more than a thousand years. In this study, a pharmacodynamics
combined urinary metabonomic study using UPLC-Q-TOF-HDMS was performed to assess the holistic
eﬃcacy of the Traditional Chinese Medicine (TCM) Wu-tou formula for treating RA in rats. Eighty male
Sprague-Dawley rats were randomly divided into eight groups, named as the healthy control group
(HG), the model group (AIA), the WTF group and five single herb groups. The treatment groups and the
model group were induced for treating rheumatoid arthritis by using complete Freund’s adjuvant.
Histological results assessed the joint damage and several biochemical parameters such as IL-1b, TNF-a,
SOD and MDA were used to evaluate inflammation injury and oxidative stress. Based on the results, a
metabonomic investigation was conducted to study the mechanism of the WTF and single herb
treatment groups for treating RA. Multivariate statistical analyses such as PCA and OPLS-DA were used
to identify potential biomarkers in urine. As a result, twenty-six potential biomarkers have been found by
comparison with the model and the WTF treatment group. The potential biomarkers mainly aﬀect the
phenylalanine, tyrosine and tryptophan biosynthesis pathway and the taurine and hypotaurine
metabolism pathway. Aconiti Radix Preparata and Ephedrae Herba showed better eﬀects on treating RA
from the integrated evaluation by histological results, biochemical parameters and pattern recognition
analysis. A comprehensive evaluation of the diﬀerent therapeutic eﬀects and the mechanism of each
herb in the WTF for treating RA was performed in this research.
Introduction
Rheumatoid arthritis (RA) is a systemic autoimmune disease,
involving the chronic and abnormal inflammatory disease of
synovial joints, progressive destruction of cartilage and bone.
The articular and extra-articular characteristics of RA include
synovial hypertrophy, bone oedema, cartilage destruction,
pulmonary fibrosis, pericardial inflammation, mononeuritis,
an increase in aminotransferase concentrations and vasculitis.1
Patients aﬀected with RA usually have a risk factor to cardio-
vascular disease,2 pulmonary embolism and deep vein throm-
bosis.3 The cardiovascular risk is due to the high inflammatory
which might be caused by RA.4 The tumour necrosis factor a
(TNF-a) and interleukin (IL) are the main cytokines in the
process of synovitis and joint destruction.5 Moreover, oxidative
stress is an important factor for the pathogenesis of RA, which
correlates with the degrees of inflammation and joint tissue
damage.6,7 Nevertheless, there is still no specific medicine to
cure RA completely, thus it is necessary to further investigate the
pathogenesis. In recent years, non-steroidal anti-inflammatory
drugs (NSAIDs) and disease-modifying antirheumatic drugs
(DMARDs) are commonly used. However, due to the side eﬀects
like liver and gastrointestinal disorders, the clinical uses of these
drugs are limited. Consequently, a new therapeutic approach and
new drugs are required for the treatment of RA. At present,
traditional Chinese medicine (TCM) is widely used for the treat-
ment of RA, because the formula of TCM usually contains
multiple herbs and components, which might suit multiple
targets of diseases. Therefore, the studies on TCM to treat RA
are performed more and more extensively.
Chinese medicine theory considers that a formula containing
several herbs could enhance the curative eﬀect and reduce the
toxicity due to their synergistic actions. For example, the Wu-tou
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Formula (WTF) is a classical formula mainly used to treat RA
with excellent clinical eﬀects, which contains five single herbs
including Aconiti Radix Preparata (Aconitum carmichaeli Debx.),
Ephedrae Herba (Ephedra sinica Stapf), Paeoniae Radix Alba
(Paeonia lactiflora Pall), Astragali Radix (Astragalus membranaceus
(Fisch.) Bge.) and Glycyrrhiza Radix Preparata (Glycyrrhiza uralensis
Fisch.). Among which, Aconiti Radix Preparata as the main herb
in the WTF plays a major role as an analgesic and to disperse
moisture in joints, but its toxic eﬀects were frequently reported
since it has a narrow therapeutic range;23 Ephedrae Herba
assists Aconiti Radix Preparata to enhance the anti-rheumatic
eﬃcacy, because it can prompt the useful components to reach
the joints; Astragali Radix strengthens the immune system in
the body; Paeoniae Radix Alba reduces the pain of bones and
muscles; Glycyrrhiza Radix Preparata produces anti-inflammatory
eﬀects, mainly reduces the toxicity of Aconiti Radix Preparata and
so on.8–10
Metabonomics defined in 1999 by Nicholson is mainly used
to study small-molecule metabolite profiles extracted from
biofluids, cells or tissues. In recent years, it has been widely
applied to toxicological survey, functional genomics, plants and
microbes, clinical diagnostics and nutritional biochemistry.11,12
TCM as a multi-compound and multi-target system is suitable
for the method of metabonomics, owing to the commonness
of the holistic value and integrity of dynamic alteration
information of the body. Nuclear magnetic resonance (NMR)
and mass spectrometry (MS) are two main approaches for the
study of metabonomics. Compared with NMR, MS is more
sensitive and versatile to the selective ionization method
and the detector. MS conjugated with separation techniques
such as gas chromatography-mass spectrometry (GC-MS),
high-performance liquid chromatography-mass spectrometry
(HPLC-MS), or capillary electrophoresis-mass spectrometry
(CE-MS), could greatly increase the specificity and resolution,
and reduce the complexity of the mass spectrum to be used for
further processing.13 Recently, high definition mass spectro-
metry (HDMS) coupled with ultra-performance liquid chroma-
tography (UPLC) dominated the metabonomics arena, since
this method could accurately identify the metabolite mass in a
short time. In our earlier studies, the eﬀect of the Wu-tou
Formula on endogenous metabolites in urine of rats with RA was
observed by the metabonomic method using ultra-performance
liquid chromatography coupled with quadrupole time-of-flight
high definition mass spectrometry (UPLC-Q-TOF-HDMS). The
changes in the metabolite pathway after treatment with the WTF
have been investigated using pattern recognition approaches.8
However, the eﬀective substance and the mechanism of the WTF
have not been elucidated, and single herb actions on rats with
RA as well as the metabolic pathways are not clear. In this study,
the eﬀects of five kinds of single herbs were evaluated by
pathological variation of right hind joints and serum bio-
chemical parameters on the model of adjuvant-induced arthritis
(AIA) rats. On the basis of these studies, the metabolic pathways
influenced by each herb were investigated using the meta-
bonomic method to elucidate the integral mechanism for
treating RA.
Results and discussion
Pharmacodynamics to assess the holistic eﬃcacy of the WTF
Serum biochemical parameters. IL-1b and TNF-a played a
central role in synovitis and joint destruction, and a quantita-
tive analysis showed that they both are present in high concen-
tration in synovial fluid and synovial tissue.14 By measuring the
concentrations of the two cytokines in serum via ELISA kits, it
was found that the two cytokines up-regulated in the model
group showed a significant inflammation response in rats with
RA ( p o 0.01) (Fig. 1). Compared with the model group, the
level of the inflammatory cytokines in serum declined signifi-
cantly ( p o 0.01) in the WTF treatment group. The five single
herb treatment groups also presented a certain degree of
therapy eﬃciency. ZCW and MH significantly reduced the
concentrations of TNF-a and IL-1b; HQ down-regulated the
level of TNF-a and GC exhibited the eﬀect of the reduced
IL-1b level in serum. Of all the five herbs, ZCW and MH showed
a better eﬀect to reduce the two cytokines in serum.
Oxidative stress related to the pathogenesis of autoimmune
disease like RA.
Peroxide radicals were generated in the inflammatory
process and caused damage to the body. SOD induced the
production of peroxide that was converted into hydrogen per-
oxide and oxygen, thereby clearing the radicals, and showed an
anti-inflammatory eﬀect. MDA is one of the most important
peroxide products of membrane lipid, which could exacerbate
damage to the membrane. Obviously, the AIA rats suﬀered
oxidative stress with a low SOD activity and a high MDA level
in serum (Table 1). By comparing the SOD and MDA concen-
trations between the treatment groups, ZCW, MH and BS
showed the major antioxidant eﬀect in the WTF as they could
significantly decrease MDA concentration and increase SOD
activity. HQ and GC showed less antioxidant capacity in the
formula.
Histological results. As shown in Fig. 2A, there is no sign of
inflammation in the right joint section of the healthy group,
Fig. 1 Concentrations of IL-1b and TNF-a in serum of the study groups,
after 3 week treatment.
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while the model group had serious synovial proliferation, cell
inflammation, cartilage destruction and bone erosion. The
synovial plica had mild hyperplasia of intra-articular in WTF,
ZCW and MH groups, meanwhile synovial proliferation, cell
infiltration and moderate inflammation appeared in BS, HQ
and GC groups. A total of 16 scores were used to evaluate the
inflammatory level, which included inflammatory infiltration,
synovial proliferation, cartilage erosion, and bone destruction
from 0 to 3 scores, respectively. Scoring was proportional to the
joint damage (Fig. 2B). From the results, it can be seen that WTF,
ZCW and MH groups exhibited significant therapeutic eﬀects.
Metabonomic study to assess the holistic eﬃcacy of the WTF
Biomarker characterization in a urinary metabonomic study.
Typical urinary base peak intensity chromatograms obtained in
positive and negative ion modes are shown in Fig. 3. As an
Fig. 2 (A) Histopathologic analyses of right hind joints with haematoxylin and eosin stain (original magnification 100 diameters); (B) 16 scores to evaluate
the inflammatory levels, for inflammatory infiltration, synovial proliferation, cartilage erosion, and bone destruction from 0 to 3 for each aspect.
(*p o 0.05, **p o 0.01, compared to the model group).
Table 1 SOD activities and MDA contents in serum of diﬀerent groups (mean  SD)
HG AIA WTF ZCW MH BS HQ GC
SOD (U mL1) 138.43  3.56** 126.01  5.22 137.40  8.00** 132.98  3.00** 133.43  4.14** 133.10  2.53** 129.16  4.24 131.28  5.54
MDA
(nmol mL1)
6.30  1.02** 10.00  1.80 7.67  1.42** 7.63  0.84** 7.99  0.71* 7.55  2.34** 8.61  1.91 7.91  0.88*
vs. model group, **p o 0.01, *p o 0.05.
Fig. 3 The typical urinary base peak intensity (BPI) chromatograms. The left BPI chromatograms were the treatment groups in the positive ion mode and
the right BPI chromatograms were the treatment groups in the negative ion mode.
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unsupervised pattern recognition method, principle component
analysis (PCA) was used to construct a model to reduce the data
dimensions, and to eliminate coexisting as well as overlap
chemical information. With the PCA analysis, diﬀerent sample
groups were classified and the abnormal points were found out.
As shown in Fig. 4, diﬀerent groups have evident variations
after administration of each herb for 35 days, and the distance
far from the AIA group or the HG group gave an intuitive result
which indicated the trends of the therapeutic eﬀect. However,
the PCA method has some defects, such as it is vulnerably
influenced by the data scale. Thus, orthogonal projection to
latent structure squares-discriminant analysis (OPLS-DA) as a
supervised method was used to classify the samples correctly,
eliminate the unreasonable assumptions and further optimize
the model. The intensities of metabolites identified in first 8
min of each TIC were compared for observing the metabolic
alteration. The potential biomarkers were identified by compar-
ing the model group and treatment groups, and the variable
importance in the projection (VIP) values of these biomarkers
was greater than 1.0. The precise molecular masses and fragment
ions obtained from UPLC-HDMS of the potential biomarkers and
corresponding reference standard compounds were searched in
HMDB (http://www.hmdb.ca/spectra/ms/search), of which, these
markers were conformed by MassBank (http://www.massbank.jp/)
and ChemBank (http://chembank.med.harvard.edu/). Following
these thresholds above, 26 endogenous metabolites in urine were
recognized to be potential biomarkers, which were related to the
influence of the WTF on RA rats (Table 2). Subsequently, the
Fig. 4 PCA score plots of rat urine metabolic profiles of WTF, ZCW, MH, HQ, BS, GC, HG and AIA groups. (A) positive ion mode; (B) negative ion mode.
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levels of the above 26 potential biomarkers were analyzed in
the five single herb treatment groups to study the metabolic
pathways based on their respective roles in the WTF.
Metabolic pathway analysis. MetPA (http://metpa.metabolo
mics.ca) is a web-based metabonomic tool used to perform
pathway analysis and visualization of quantitative metabo-
nomic data. With the potential biomarkers being imported, a
holistic pathway analysis can be carried out and the important
metabolic pathways can be intuitively displayed. Table 3 shows
the main metabolic pathways aﬀected by treating AIA rats using
the WTF and each single herb. Also, the impact factor of the
WTF acting on AIA rats is listed in this table. Correlation
networks of the main potential biomarkers in response to the
therapeutic eﬀects of the WTF on AIA rats are intuitively
described in Fig. 5. Under the name of the potential biomar-
kers, one rectangular strip is composed of five diﬀerent colors
respectively to represent the five single herb groups, and the
length of each colored bar suggests the relative treatment
Table 2 Potential biomarkers identified in WTF treatment group compared to model group and found in each monotherapy group
Mode
Rt
(min)
VIP
value
Accurate
mass
Measured
mass
Error
(ppm) Formulae Biomarkers Found in diﬀerent group
ESI+ 3.10 1.26 166.0863 166.0866 2.1 C9H11NO2 L-Phenylalanine ZCW
1.28 1.25 190.0499 190.051 6.0 C10H7NO3 Kynurenic acid ZCW MH HQ
3.80 1.25 250.0475 250.0471 1.6 C8H12NO6P Pyridoxine 50-phosphate* HQ
3.20 1.23 340.1027 340.104 3.8 C15H17NO8 5-Hydroxy-6-methoxyindole
glucuronide
BS GC
3.01 1.13 180.0655 180.0663 4.3 C9H9NO3 Hippuric acid ZCW MH HQ BS
3.20 1.11 164.0706 164.0714 4.8 C9H9NO2 3-Methyldioxyindole GC
3.30 5.13 216.0632 216.0637 2.5 C5H14NO6P Glycerylphosphorylethanolamine ZCW HQ GC
3.30 3.34 194.0812 194.0819 3.8 C10H11NO3 2-Methylhippuric acid* ZCW MH BS GC
3.30 2.05 76.0393 76.0392 1.4 C2H5NO2 Glycine* MH GC
0.77 2.05 136.0397 136.0397 0.0 C4H9NO2S Homocysteine* ZCW HQ BS GC
0.63 1.95 166.0723 166.0732 5.2 C6H7N5O 3-Methylguanine ZCW MH BS GC
0.61 1.78 114.0662 114.0668 5.4 C4H7N3O Creatine ZCW MH
0.65 2.80 144.1019 144.1026 4.8 C7H13NO2 Proline betaine ZCW HQ GC
2.60 1.85 206.0448 206.046 5.9 C10H7NO4 Xanthurenic acid ZCW MH HQ
ESI 3.80 1.67 175.0248 175.0257 5.1 C6H8O6 Ascorbic acid MH BS
3.97 1.24 173.0819 173.0832 7.3 C8H14O4 Suberic acid ZCW MH HQ GC
5.97 1.97 201.1132 201.1128 2.2 C10H18O4 Sebacic acid MH
3.49 5.59 107.0502 107.05 2.2 C7H8O p-Cresol
0.80 1.30 182.0459 182.0468 5.0 C8H9NO4 4-Pyridoxic acid
0.51 1.15 124.0074 124.0078 3.3 C2H7NO3S Taurine
2.88 2.03 273.00 273.00 1.4 C6H11O10P D-Glucuronic acid 1-phosphate MH
3.08 1.68 222.0772 222.0784 5.5 C11H13NO4 N-Acetyl-L-tyrosine
0.70 1.35 191.0197 191.02 1.4 C6H8O7 Citric acid ZCW MH HQ GC
3.80 8.39 283.0823 283.0837 4.9 C13H16O7 p-Cresol glucuronide ZCW MH BS GC
2.79 5.54 212.0023 212.0031 3.8 C8H7NO4S Indoxyl sufate MH HQ BS GC
3.49 5.59 187.0071 187.0077 3.5 C7H8O4S p-Cresol sulfate ZCW MH BS
Note: biomarkers with asterisk are interfered by WTF.
Table 3 The main pathway aﬀects by WTF and the five single herbs acted on RA
Pathway name
Group
WTF (impact factor) ZCW MH HQ BS GC
Phenylalanine, tyrosine and tryptophan biosynthesis 0.50000 m
Taurine and hypotaurine metabolism 0.42857
Phenylalanine metabolism 0.40741 m
Valine, leucine and isoleucine biosynthesis 0.33333
Glyoxylate and dicarboxylate metabolism 0.29630 m m m m
Glycine, serine and threonine metabolism 0.29197 m m
Pentose and glucuronate interconversions 0.27273 m m
Citrate cycle (TCA cycle) 0.08044 m m m
Primary bile acid biosynthesis 0.05952 m m
Vitamin B6 metabolism 0.04902 m
Tryptophan metabolism 0.04230
Starch and sucrose metabolism 0.03778 m m
Glycerophospholipid metabolism 0.02315 m m m
Purine metabolism 0.02077
Arginine and proline metabolism 0.01198 m m
Glutathione metabolism 0.00573 m m
Alanine, aspartate and glutamate metabolism 0.00316
Note: the black triangle (m) marked in a single herb group indicates that the corresponding metabolic pathway has been aﬀected.
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influence of the herb on AIA rats (the length/percentage was
obtained by averaging the relative concentrations of the five
single treatment groups).
Markers aﬀected by WTT treatment. Obviously, the bio-
markers were found by comparison with the WTF treatment
group and the AIA model group, and the level of the potential
biomarkers in urine could not be always regulated to the normal
level. These markers might be disturbed by WTF interference,
including pyridoxine 50-phosphate, 2-methylhippuric acid, glycine
and homocysteine (see Table 2).
Markers related to WTF therapeutic eﬀects. All the change
trends of the potential biomarkers in diﬀerent groups are
shown in Fig. 6. Vitamin C is considered as an antioxidant
and functions as a reducing agent and coenzyme in several
metabolic pathways. The ability of vitamin C to donate electrons
also makes it a potent water-soluble antioxidant that readily
scavenges free radicals, such as molecular oxygen, superoxide,
hydroxyl radicals and hypochlorous acid. Lamers et al. aimed to
identify a metabolic fingerprint for osteoarthritis (OA), and they
found that vitamin C could correct metabolic abnormalities after
interventional therapy, which means that vitamin C had a notice-
able eﬀect on the development of OA.15 In this study, we noticed
that the vitamin C level decreased in the AIA group compared
with the HG group, while the content increased after treated by
WTF. Among all the single herbs, the most important component
is ZCW followed by MH to compare with the other herbs in the
formula (see Fig. 6). Phenylalanine, an essential amino acid of
humans, plays an important role in the body, whose precursor is
tyrosine, or dopamine, or norepinephrine or adrenaline. Phenyl-
alanine is converted to hippuric acid by the metabolism of
intestinal bacteria and then excreted as hippuric acid in urine.
It could be observed that an increase of phenylalanine concen-
tration along with a decrease of hippuric acid content in the
model group indicates that the AIA group had a lower intestinal
bacterial activity compared with the normal group. The change
levels of these two markers indicated that the phenylalanine
pathway had been disturbed in AIA rats. Certain therapeutic
eﬀects appeared after treatment with the WTF and single herbs,
here the WTF showed a significant eﬀect in regulating the two
biomarker contents. In the five single herb treatment groups, the
relative influences of ZCW, MH, HQ, BS and GC to regulate
phenylalanine were 27%, 14%, 20%, 20% and 19%, and the
relative influences to regulate hippuric acid were 16%, 20%, 11%,
36% and 17%, respectively. The results indicated that BS and
ZCW mostly contributed to aﬀect intestinal bacteria metabolism
in the WTF.
P-Cresol, p-cresol glucuronide and p-cresol sulfate (PCS) are
the major uremic toxins and the latter two compounds mainly
circulate the metabolite of p-cresol through the intestinal
membrane or are glycosylated in the liver. P-Cresol plays an
important role in the immunodeficiency of uremia.16 Renal
tubular secretion is the main way to clear them from the body.
Fig. 5 Correlation networks of main potential biomarkers in response to the therapeutic eﬀects of WTF on AIA rats. The identified potential biomarkers
are marked as red; one rectangular strip under the potential biomarker contains five diﬀerent colors respectively corresponding to the five single herbs,
and the length of a color is the relative influence of a herb.
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These compounds could accumulate in the blood with decreasing
excretion due to kidney failure.17,18 As a systemic inflammatory
disorder disease, RA is always associated with renal injury and
toxin accumulation.1 In this research, compared with the model
group, the level of p-cresol and its metabolites in all treatment
groups increased obviously. The results showed that the WTF
could increase the secretion of these toxic substances, and the five
single herbs are eﬀective in promoting the toxins excreted from the
body (see Fig. 6).
Tryptophan (TRP) metabolism impacts the immune system
mainly via the kynurenine pathway, in which indoleamine-2,3-
dioxygenase (IDO) plays a pivotal role as a rate-limiting enzyme.
Kynurenic acid could reduce N-methyl-D-aspartate receptor
(NMDAR) activity and disturb brain functions as a neuro-
protective molecule.19 It has been demonstrated that kynurenic
acid is attributed to inhibit synovial proliferation in RA.20
However, both xanthurenic acid and kynurenic acid are down-
stream products of the kynurenine pathway, down-regulating in
model rats and little fine-tuned after diﬀerent treatment
groups. From Fig. 6, it can be seen that ZCW as a main herb
exhibited a good eﬀect even better than the WTF. The quanti-
tative analysis results obtained by us indicate that not only the
quantities of xanthurenic acid and kynurenic acid, but also the
ratio between these two compounds is important, which is the
possible mechanism of the WTF for treating RA, which might
be due to the decrease of the activity of IDO.7 The evidence
obtained by scientists to date indicates that inflammation
symptoms are highly related to the increase of IDO activity.21,22
3-Methyl-dioxyindole is a product from TRP metabolism;23 the
amount of that compound increased significantly in urine of
the ZCW group, which indicates that the disorder of tryptophan
metabolism was mainly caused by ZCW. It can be verified from
Fig. 5 that tryptophan metabolism was aﬀected significantly by
ZCW, since the longest color in the rectangular color strip
under the markers is ZCW.
Glucuronidation usually occurs in the liver, the toxic sub-
stances bonded to glucuronic acid have high water solubility and
thereby they are more readily excreted from the body. 5-Hydroxy-
6-methoxyindole glucuronide is produced from tryptophan meta-
bolism. In this work, the level of 5-hydroxy-6-methoxyindole
glucuronide increased in the model group, which might be due
to some indole compounds excreted into urine after glucuronida-
tion. From Fig. 6, it can be seen that the WTF could significantly
reduce the level of 5-hydroxy-6-methoxyindole glucuronide com-
pared with the model group. Of interest, the five single herbs
showed diﬀerent regulation trends, such as ZCW could increase
Fig. 6 Relative intensities of potential biomarkers in diﬀerent groups. (*p o 0.05, **p o 0.01, compared to the model group).
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the concentration of 5-hydroxy-6-methoxyindole glucuronide
significantly in urine, but BS and GC revealed a diametrically
opposite function. ZCW though play an important role in WTF,
its toxicity still harmful to the body. However, BS and GC through
the interactions with other herbs could reduce the toxicity of
ZCW and strengthen its eﬀect.
Taurine, synthesised via cysteine and vitamin B6, is an
essential amino acid and acts as the next most important
inhibitory neurotransmitter in the brain. The biological functions
of taurine include anti-oxidation, Ca2+ transport regulation, and
anti-inflammation. And more, taurine chloramine could sup-
press the secretion of TNF-a in vivo.24 After ranking the impact
factor obtained from MetPA, the taurine and hypotaurine meta-
bolism pathway was the next major metabolic pathway in the
WTF for treating AIA rats. By the relative content analysis (Fig. 6),
all the herbs could improve the low contents of taurine in the
model group after treatment, in which ZCW made a greater
contribution.
4-Pyridoxic acid and pyridoxine 50-phosphate are meta-
bolites of vitamin B6, both the compounds decreased in urine
of model rats. A report suggested that patients with RA required
a higher vitamin B6 supplement than normal healthy popula-
tion, so as to repair the subnormal vitamin B6 level.25 Vitamin
B6 is closely related to the metabolism of amino acids because
it acts as a coenzyme in decarboxylation and transamination.
From the pathway analysis results (Table 3), we can see that
HQ obviously played a vital role in the vitamin B6 metabolic
pathway. HQ was enriched with flavonoid glycosides, triterpene
saponins and astragalus polysaccharides which respectively
showed significant cellular immune and anti-tumor functions.26–28
It has been reported that astragaloside IV exhibits antiarthritic
activity by suppressing macrophage activation and decreasing
IL-1b concentration to alleviate cartilage and bone destruction in
AIA rats.29 Astragalus polysaccharides could strongly suppress
NF-kB activation and down-regulate TNF-a and IL-1b expressions
in cell experiment.30 As far as we know, it is the first report on
HQ attenuated arthritis by impacting the vitamin B6 metabolic
pathway in vivo.
Citric acid is formed in the tricarboxylic acid (TCA) cycle,
which is associated with energy metabolism.31 The level of
urinary citrate excretion was used as a criterion to diagnose
kidney stones, and hypocitraturia was often regarded as renal
tubular acidosis and bone disease.32 The decreased level of
citric acid (see Fig. 6) suggested the break down of an aberrant
energy metabolism in the model group. After treatment, the
WTF could modulate the downward trend of the level in urine.
Among the five single herbs, HQ showed a good eﬀect on
energy metabolism, probably because of the enhancement of
vital Qi corresponding to the related theory on TCM.
Glycerylphosphorylethanolamine (GPE) is a growth stimulant
for hepatocytes, which exhibits potential ability to recover astro-
cytes, and could protect these astrocytes from inflammation,
gliosis and neurodegeneration. The bio-function of astrocytes is
mainly related to chronic inflammation, and these cells over
produce inflammatory cytokines and mediators, exacerbating
the progression of many neuropathologies.33 This is the first
report on GPE used as a biomarker in inflammation diseases.
The results obtained by us showed that the obvious increase of
GPE in model rats might cause the growth of astrocytes, and
thus probably increase the secretion of inflammatory cytokines.
The WTF showed a significant treatment eﬀect in reducing the
content of GPE in urine; ZCW combined with other herbs in
this formula played an important role. Suberic acid and sebacic
acid are saturated straight-chain dicarboxylic acids with 8 or
10 carbon atoms, respectively, and are present in the urine of
patients with fatty acid omega-oxidation disorders.34 The
decreased levels of suberic acid and sebacic acid in the urine
of the model group were possibly due to the oxidation disorders
of fatty acid. All the treatment groups exhibited excellent regula-
tion eﬀects, since they could up-regulate the content of the two
dicarboxylic acids in urine except for the MH treatment group.
Recently, Zhang et al. reported a theoretical research study
that combined system biology and network pharmacology to
elucidate the pharmacological mechanisms of the WTF for
treating RA.35 Based on the results obtained in this research,
they concluded that Aconiti Radix Preparata exhibited the most
important common eﬀect on Ephedrae Herba, while the less
common eﬀect on Glycyrrhiza Radix Preparata and Paeoniae
Radix Alba. In this study, the metabolomic method as a power-
ful approach was used to distinguish the therapeutic eﬀects
among diﬀerent treatment groups (see the PCA score of Fig. 4).
Equally, by the comprehensive evaluation of biochemical para-
meters, histopathologic assessment, biomarker and metabolic
pathway analysis, one could conclude that ZCW played a major
role in the treatment of RA using the WTF followed by MH. HQ,
BS and GC displayed synergistic actions to facilitate the eﬀec-
tiveness. To our knowledge, this is the most comprehensive
research to elucidate the therapeutic eﬀects of diﬀerent herbs
in the WTF for treating RA.
Conclusion
Nowadays, TCM shows significant advantages in the treatment
of chronic diseases. As an important part of TCM, the formula
possessing multi-target and multi-component characteristics
always presents good curative eﬀects. In this paper, a pharma-
codynamics and urinary metabonomic study was performed to
assess the eﬃcacy of the WTF and the single herbs on AIA
model rats. The results revealed that diﬀerent herbs in the WTF
disturbed diﬀerent metabolic pathways, and the main meta-
bolism pathways of the WTF for treating RA were the phenyl-
alanine, tyrosine and tryptophan biosynthesis pathway; the
taurine and hypotaurine metabolism pathway; and the phenyl-
alanine metabolism pathway. ZCW as the important component
mainly aﬀected the phenylalanine, tyrosine and tryptophan bio-
synthesis pathway; the phenylalanine metabolism pathway; and
the glyoxylate and dicarboxylate metabolism pathway. MH as
the ministerial component mainly aﬀected the glyoxylate and
dicarboxylate metabolism pathway; the glycine, serine and
threonine metabolism pathway; and the citrate cycle metabo-
lism pathway. ZCW and MH showed good treatment eﬀects on
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RA, while HQ, BS and GC displayed synergistic actions to
facilitate the eﬀectiveness.
Materials and methods
Materials
Aconiti Radix Preparata, Ephedrae Herba, Paeoniae Radix Alba,
Astragali Radix and Glycyrrhiza Radix Preparata were purchased
from Ji Lin Pharmacy. All the herbs met the standards recorded
in Chinese Pharmacopoeia (2010 Edition) and identified by Prof.
Shumin Wang (Changchun University of Chinese Medicine).
Complete Freund’s adjuvant (CFA) was taken from Chondrex,
Inc. (Redmond, WA, USA). L-Phenylalanine, kynurenic acid,
glycine, homocysteine, xanthurenic acid, 2-methylhippuric acid,
ascorbic acid, suberic acid, sebacic acid, taurine, N-acetyl-L-
tyrosine, citric acid, hippuric acid were supported by Sigma-
Aldrich (St. Louis, Mo, USA). Leucine enkephalin and sodium
formate were obtained from Waters (Milford, USA). Acetonitrile
and formic acid, HPLC-grade, were obtained from Fisher Scien-
tific (Loughborough, UK). Ultrapure water was prepared using a
Milli-Q plus (Milford, MA, USA). Rat IL-1b ELLSA kits, TNF-a
ELLSA kits, superoxide dismutase (SOD) kits andmalondialdehyde
(MDA) kits were obtained from Nanjing Jiancheng Bioengineering
Institute (Nanjing, China).
Extractions
The preparation method of WTF extraction was described in a
previous report:9 a total of 900 g crude herbs, including Aconiti
Radix Preparata, Ephedrae Herba, Paeoniae Radix Alba, Astra-
gali Radix and Glycyrrhiza Radix Preparata at the 2 : 3 : 3 : 3 : 3
ratios were immersed in 9 L of water for 1 h, and then heated to
reflux for 1.5 h. The extraction solution was filtered and the
drugs were put into another 7.2 L of water and refluxed for
1.5 h. All the filtered extraction solutions were combined and
concentrated to 600 mL. Aconiti Radix Preparata, Ephedrae
Herba, Paeoniae Radix Alba, Astragali Radix and Glycyrrhiza
Radix Preparata were extracted using the procedure of WTF
extraction, and concentrated to 1.5 g mL1, respectively.
AIA model and treatment
Male Sprague-Dawley rats (weights 200  20 g) were supplied by
Dalian Medical University (Dalian, China). All rats were randomly
divided into 8 groups respectively containing 10 rates, namely
the healthy control group (HG), the model control group (AIA),
the WTF treatment group (WTF), the Aconiti Radix Preparata
treatment group (ZCW), the Ephedrae Herba treatment group
(MH), the Paeoniae Radix Alba treatment group (BS), the Astragali
Radix treatment group (HQ) and the Glycyrrhiza Radix Preparata
treatment group (GC). Rats were housed under standard laboratory
conditions (temperature, 22  2 1C; relative humidity, 50  5%),
and food and water were supported ad libitum throughout the
whole experiment. The rats were accommodated for 1 week and
then fed in metabolism cages for another 24 h before initiating
the experiment. All rats were fasted 24 h before collecting urine
and sacrificing. The rats in the model and treatment groups
were respectively injected 0.1 mL of CFA in the left hind digits
while the rats in the control group were injected 0.1 mL 0.9%
saline solution at the same time. The AIA model was constructed
after 2 week immunization. The rats in the WTF treatment group
were administered intragastrically withWTF extraction at a dose of
9.8 g crude drug per kilogram per day (equal to 10 mL per kg per
day) as reported in a previous study;9 the ZCW treatment group
was administered intragastrically with Aconiti Radix Preparata
extraction at a dose of 1.4 g crude drug per kilogram per day
(equal to 10 mL per kg per day); MH, BS, HQ and GC treatment
groups were administered intragastrically with each extraction at a
dose of 2.1 g crude drug per kilogram per day (equal to 10 mL per
kg per day). The rats in the healthy control and AIA model group
were administered with distilled water 2 mL per day. All the rats
were administered for 3 weeks. All the experimental procedures
were performed in accordance with the Guide for the Care and Use
of Laboratory Animals.
Sample collection and preparation
The serum sample was obtained from the whole blood after 21
days of administration, upon centrifugation at 3500 rpm at 4 1C
for 10 min to get the supernatant. The serum samples were
stored immediately at 80 1C. Prior to biochemical parameter
analysis, the serum samples were thawed at 4 1C. The levels of
TNF-a and IL-1b in serum were determined using commercial
ELISA kits. SOD and MDA levels were determined by using
commercial SOD and MDA kits.
The right hind joints were kept after the rats were sacrificed,
and soaked in 10% formalin solution for a week to fix the joint,
then decalcified in Gooding and Stewart’s solution for two
weeks. Joint sections were stained with haematoxylin and eosin
(H&E) for general evaluation. A total of 16 grades of the
evaluation were established, for inflammatory infiltration,
synovial proliferation, cartilage erosion, and bone destruction
graded from 0 to 3 for each aspect as previously reported.36
Samples of 24 h urine of rats were collected weekly from the
metabolism cages, and a test tube with an ice pack was used so
as to keep the urine at a low temperature. The urine was
centrifuged at 12 000 rpm at 4 1C for 10 min to remove particle
contaminants, and the supernatant was stored at 80 1C. The
supernatant was thawed at 4 1C and diluted with 10 times of
ultrapure water, and then filtered through a 0.22 mm filter
membrane before UPLC-MS analysis.
UPLC-MS conditions
Chromatographic analysis was performed using a Waters
Acquity UPLC system coupled with a Q-TOF SYNAPT G2 High
Definition Mass Spectrometer (Waters, UK). The separation
was carried out by a Waters ACQUITY UPLC BEH C18 Column
(2.1 mm  50 mm, 1.7 mm) at 40 1C. An aliquot of 5 mL of
sample solution was injected into the column for each run. The
mobile phase consisted of a linear gradient of A (0.1% formic
acid in water) and B (acetonitrile) with a constant flow rate of
0.3 mL min1. The gradient program was optimized as follows:
5% B at 0–1.6 min, 5–15% B at 1.6–2 min, 15% B at 2–3.8 min,
15–35% B at 3.5–5.5 min, 35–40% B at 5.5–6 min, 40–100% B at
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6–8 min. The sample room was maintained at 4 1C during the
whole analysis. By comparing with the peak intensity, optimal
conditions of the mass spectrometer were set (source tempera-
ture at 120 1C, desolvation gas temperature at 350 1C, cone
desolvation gas flow rate at 50 L h1, desolvation gas flow rate
at 700 L h1). For the positive ion mode, the capillary voltage
was 3.0 kV, the cone voltage was 30 V and the extraction cone
voltage was 5.0 V. For the negative ion mode, the capillary
voltage was 2.5 kV, the cone voltage was 30 V and the extraction
cone voltage was 5.0 V. MS data were centroided in the full-scan
mode from 50 to 1000 Da with a 0.3 s scan time and a 0.1 s inter
scan delay. Sodium formate was used to set up mass spectrometer
calibration. Leucine enkephalin (2 ng mL1) was used as the
lockspray at a flow rate of 5 mL min1, the accurate molecular
weight was 554.2615 and 556.2771 in the negative and the positive
mode, respectively. Argon was used as the collision gas. The MSE
mode was applied to obtain the fragment information of potential
biomarkers. The energy was first kept at 25 eV, and was regulated
depending on the fragmentation.
Urine sample analysis
As is necessary to optimize the UPLC-Q-TOF-HDMS conditions
and access the data quality before and during the analysis, the
‘‘quality control’’ (QC) sample was needed. Therefore all the
urine samples, 100 mL of each, were mixed as the QC sample.
The run order of the entire sample set was random. Before
analysis, 5 QC samples were run to equilibrate the system, and
then a QC sample was injected at a regular interval (every ten
samples) throughout the analytical run to observe the repeat-
ability and stability of the system.37
Pattern recognition analysis and data processing
The UPLC Q-TOFMS raw data were first processed by MarkerLynx
Application Manager and MassLynxV4.1 for compound detection
and peak alignment. After the first processing, the data complexity
was reduced and the interferences were eliminated. Then the
exact mass, retention time and the intensities as a data matrix
were imported into EZinfo 2.0, a multivariate statistical analysis
software. Principle component analysis (PCA) and orthogonal
projection to latent structures squares-discriminant analysis
(OPLS-DA) were conducted to assess the trend of disease, thera-
peutic eﬀect and to find the biomarkers. The biochemical data
were introduced into PASW Statistics 18.0 software for statistical
analysis, and the p value of less than 0.01 was selected as
significant statistical diﬀerences. Available biochemical data-
bases, such as ChemBank (http://chembank.med.harvard.edu/),
MassBank (http://www.massbank.jp/), HMDB (http://www.hmdb.
ca/spectra/ms/search), METLIN (http://metlin.scripps.edu/) and
KEGG (http://www.kegg.com/) were used to identify potential
biomarkers and construct the metabolic pathway.
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